December 12, 2023 Comments Off on New patent for TEVA drug AUSTEDO XR Posted in: Patent Added Annual Drug Patent Expirations for AUSTEDO+XR Austedo Xr is a drug marketed by Teva and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for TEVA drug AUSTEDO XR appeared first on DrugPatentWatch – …
December 12, 2023 Comments Off on New patent for Boehringer Ingelheim drug PRADAXA Posted in: Patent Added Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from four suppliers. There are four patents…
The post New patent for Boehringer Ingelheim drug PRADAXA appeared f…